who is a good candidate for glp 1 Are you GLP-1 medication? Here what most platforms are not telling you. π, GLP-1 drugs like semaglutide and tirzepatide are revolutionary. They are changing the landscape of Who is (and is Not)
Description
Receptor-targeted photodynamic therapy of Glucagon-like peptide 1 receptor-positive lesions
While preclinical studies support this hypothesis, robust clinical evidence remains limited
Most people regain a significant portion of lost weight within 12 months after stopping semaglutide because appetite hormones and metabolic signals return to baseline
LA received speaking and consulting fees from Pfizer, Boehringer Ingelheim, and Roche for work unrelated to this study
